ArticleEJNMMI radiopharmacy and chemistry2026

Development of NOTA-based antibody-fragment labeling agent that reduces early renal radioactivity levels.

Shunsuke Katamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.